产品
编 号：F741206
分子式：C23H44N2O5
分子量：428.61
分子式：C23H44N2O5
分子量：428.61
产品类型
规格
价格
是否有货
结构图
CAS No: 1428247-78-2
产品详情
生物活性：
IHVR-17028 is a potent and broad-spectrum antiviral agent. IHVR-17028 exhibits antiviral activity against BVDV, TCRV and DENV with EC50 values of 0.4 μM, 0.26 μM, 0.3 μM, respectively. IHVR-17028 is a potent ER α-glucosidase?I?inhibitor with an IC50 of 0.24 μM. IHVR-17028 can be used for infectious diseases research.
体内研究：
In Pharmacokinetic analysis in rats, IHVR17028 (oral gavage; 75 mg/kg) shows a Cmax?value of 0.18 μg/ml; the Tmax value is 1.56 hours; and the F% value is 12% after PO administration, the T1/2 value is 0.88 hour after iv. adminstration.IHVR-17028 (oral gavage; 25-50 mg/kg; treatment 1 day prior to virus challenging) exhibits significant protection in mouse model of lethal MARV infection.Animal Model:BALB/c mice are challenged with 1,000 PFU mouse adapted MARV via IP injection
Dosage:50 mg/kg
Administration:Treatment 1 day prior to virus challenging
Result:Exhibited protection in mouse when the treatment is initiated 1 day prior to virus challenging.
Animal Model:C57B1/6 mice challenged with 1,000 PFU mouse adapted EBOV
Dosage:25 mg/kg
Administration:Twice daily at 12 h interval; starting 4 h post infection for 10 days
Result:Inhibited EBOV infection in mice.
体外研究：
In virus yield reduction assays, IHVR-17028 inhibits viral activities with EC50 values of 0.4 μM, 0.26 μM, 0.3 μM for bovine viral diarrhea virus (BVDV) (NADL strain), tacaribe virus (TCRV) (11573 strain), DENV (serotype 2, New Guinea C), respectively. And in MTT assays, IHVR-17028 exhibits IC50 values of all >500 μM in?MDBK, Huh7.5 or BHK cells.
IHVR-17028 is a potent and broad-spectrum antiviral agent. IHVR-17028 exhibits antiviral activity against BVDV, TCRV and DENV with EC50 values of 0.4 μM, 0.26 μM, 0.3 μM, respectively. IHVR-17028 is a potent ER α-glucosidase?I?inhibitor with an IC50 of 0.24 μM. IHVR-17028 can be used for infectious diseases research.
体内研究：
In Pharmacokinetic analysis in rats, IHVR17028 (oral gavage; 75 mg/kg) shows a Cmax?value of 0.18 μg/ml; the Tmax value is 1.56 hours; and the F% value is 12% after PO administration, the T1/2 value is 0.88 hour after iv. adminstration.IHVR-17028 (oral gavage; 25-50 mg/kg; treatment 1 day prior to virus challenging) exhibits significant protection in mouse model of lethal MARV infection.Animal Model:BALB/c mice are challenged with 1,000 PFU mouse adapted MARV via IP injection
Dosage:50 mg/kg
Administration:Treatment 1 day prior to virus challenging
Result:Exhibited protection in mouse when the treatment is initiated 1 day prior to virus challenging.
Animal Model:C57B1/6 mice challenged with 1,000 PFU mouse adapted EBOV
Dosage:25 mg/kg
Administration:Twice daily at 12 h interval; starting 4 h post infection for 10 days
Result:Inhibited EBOV infection in mice.
体外研究：
In virus yield reduction assays, IHVR-17028 inhibits viral activities with EC50 values of 0.4 μM, 0.26 μM, 0.3 μM for bovine viral diarrhea virus (BVDV) (NADL strain), tacaribe virus (TCRV) (11573 strain), DENV (serotype 2, New Guinea C), respectively. And in MTT assays, IHVR-17028 exhibits IC50 values of all >500 μM in?MDBK, Huh7.5 or BHK cells.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备